Search research articles
Contact Us
Filters
Showing results (21-30 of 519) with videos related to
Page
of 52
Sort By:
Lancet (London, England)
|
June 7, 2006
Harm-reduction interventions in injection drug use
Matthew Hickman, John Macleod, Daniela De Angelis
Lancet (London, England)
|
April 4, 2006
Does cannabis use cause schizophrenia?
John Macleod, George Davey Smith, Matthew Hickman
Addiction (Abingdon, England)
|
May 8, 2018
Commentary on Lai et al. (2018): Potential and limitations of wastewater-based epidemiology in monitoring substance use
Hayley E Jones, Neil Goulding, Matthew Hickman
Biological Psychiatry
|
September 21, 2015
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Suzanne H Gage, Matthew Hickman, Stanley Zammit
F1000 Medicine Reports
|
January 31, 2013
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
Suzanne H Gage, Stanley Zammit, Matthew Hickman
Journal of Theoretical Biology
|
January 18, 2011
Mathematical modelling of hepatitis C treatment for injecting drug users
Natasha K Martin, Peter Vickerman, Matthew Hickman
Addiction (Abingdon, England)
|
August 13, 2016
Hepatitis C virus prevention and treatment prioritization-ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugs
Matthew Hickman, Natasha K Martin, Richard Huxtable
Addiction (Abingdon, England)
|
November 10, 2005
Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates
Vivian D Hope, Matthew Hickman, Kate Tilling
JAMA
|
July 17, 2003
Early exposure to marijuana and risk of later drug use
John Macleod, Matthew Hickman, George Davey Smith
Addiction (Abingdon, England)
|
January 21, 2026
Commentary on Dowd et al.: Beyond single data sources-Consistency checking and evidence synthesis for prevalence estimation
Hayley E Jones, Andreas Markoulidakis, Matthew Hickman
Page
of 52
Search research articles
Search
Showing results (21-30 of 519) with videos related to
Sort By:
Page
of 52
Lancet (London, England)
|
June 7, 2006
Harm-reduction interventions in injection drug use
Matthew Hickman, John Macleod, Daniela De Angelis
Lancet (London, England)
|
April 4, 2006
Does cannabis use cause schizophrenia?
John Macleod, George Davey Smith, Matthew Hickman
Addiction (Abingdon, England)
|
May 8, 2018
Commentary on Lai et al. (2018): Potential and limitations of wastewater-based epidemiology in monitoring substance use
Hayley E Jones, Neil Goulding, Matthew Hickman
Biological Psychiatry
|
September 21, 2015
Association Between Cannabis and Psychosis: Epidemiologic Evidence
Suzanne H Gage, Matthew Hickman, Stanley Zammit
F1000 Medicine Reports
|
January 31, 2013
Stronger evidence is needed before accepting that cannabis plays an important role in the aetiology of schizophrenia in the population
Suzanne H Gage, Stanley Zammit, Matthew Hickman
Journal of Theoretical Biology
|
January 18, 2011
Mathematical modelling of hepatitis C treatment for injecting drug users
Natasha K Martin, Peter Vickerman, Matthew Hickman
Addiction (Abingdon, England)
|
August 13, 2016
Hepatitis C virus prevention and treatment prioritization-ethical, economic and evidential dimensions of early rather than delayed treatment for people who inject drugs
Matthew Hickman, Natasha K Martin, Richard Huxtable
Addiction (Abingdon, England)
|
November 10, 2005
Capturing crack cocaine use: estimating the prevalence of crack cocaine use in London using capture-recapture with covariates
Vivian D Hope, Matthew Hickman, Kate Tilling
JAMA
|
July 17, 2003
Early exposure to marijuana and risk of later drug use
John Macleod, Matthew Hickman, George Davey Smith
Addiction (Abingdon, England)
|
January 21, 2026
Commentary on Dowd et al.: Beyond single data sources-Consistency checking and evidence synthesis for prevalence estimation
Hayley E Jones, Andreas Markoulidakis, Matthew Hickman
Page
of 52